Axelys Sante operates in Europe and the Middle East and North Africa (MENA) region through a partner network. We are also established in Algeria as a CRO approved by the Ministry of Health and Hospital Reform since July 2015.
We provide services in France…
Axelys Sante is a French CRO, founded in 2013, which is part of the AFCRO (French CRO Association).
Relying on an experienced team, we offer a full range of services to guide you throughout the life cycle of your products.
…but also in Algeria !
Axelys Sante is now taking on an international scope with a strong presence in the MENA region. Axelys Sante DZ is a company under Algerian law, approved by the Ministry of Health, Population and Hospital Reform..
The extraordinary human potential, geographical proximity and historical links between the Maghreb and Europe offer clinical trial sponsors important prospects for scientific development.
The company is part of AFCRO, Mabdesign and the World Health Partners management consulting.
Our Values
MEET THE TEAM
Lamine MAHI, MD
CEO, Axelys Sante
Specialist in Rheumatology and Immunology, Lamine completed his path with a Certificate in Medical Statistics (CESAM) and several seminars in health management, the last of which was held in 2011 at the Harvard School of Public Health. After a transition in clinical rheumatology, he joined INSERM (French National Institute of Health and Medical Research) for projects in immunology and HIV . He started his career in industry at BYK-Gulden, before joining LFB as Senior Medical Officer in Immunology and Transgene, leading clinical projects in Europe and the USA in the field of gene therapy. In 2001, he joined Gilead Sciences as Associate Medical Director in the Anti-Infectious Diseases division, a role that was later extended to Development and Clinical Operations. In June 2009, he became Director of Vifor Pharma, creating the French subsidiary of this laboratory specialized in the treatment of anemias and supportive care in oncology. In 2013, with his experience, he founded “Axelys Santé – Medical Affairs and Clinical Research”, putting all his expertise at the disposal of drug companies, to support them in their clinical development and market access strategies.
.
Sabrina BONDU
Regulatory Affairs and Quality Assurance LEADer
Sabrina is a Doctor of Pharmacy (Pharm.D.) and a Doctor of Biology (Ph.D.). She specialized in onco-hematology before joining Axelys Santé in 2019. Within the company, she is in charge of Regulatory Affairs, Quality Assurance and Medical Information. Through her duties, Sabrina actively interacts with various healthcare stakeholders: competent authorities, healthcare professionals, patient and expert associations.
Isabelle DE SOUSA
MEDICAL INFORMATION LEADER
Isabelle is in charge of the medical information department. She is entirely dedicated to the handling of requests, their qualitative treatment and their documentation. Isabelle has a Nursing degree and has been working for more than 20 years in the pharmaceutical industry. The various positions she held have enabled her to develop a wide range of medical and scientific knowledge.
Gaetan LEVILLAIN
SCIENTIFIC COMMUNICATION LEADER
Gaëtan is project manager for the medical affairs and scientific communication. He is in charge of your medical information outsourcing projects and organizes medical meetings. He holds a Master’s degree in Health and Biology (University of Nantes).
Océane TURKMENIAN
REGULATORY AFFAIRS OFFICER
Holding a Master’s degree in European Health Products Law and a Master’s degree in Pharmaceutical Law and Regulations, Océane is in charge of projects concerning the “Regulatory and Pharmaceutical Affairs” department and the management of contracts between the company and its clients or partners. She also ensures the regulatory and legal compliance of the activities carried out by Axelys Santé, while also being the reference person in terms of personal data protection. Finally, she is involved in the field of quality.
Lisa OUKACI
CLINICAL RESEARCH ASSOCIATE
Lisa graduated from the “Magistère Européen de Génétique” (MEG) and from a Clinical Research Associate (CRA) course at the University of Paris. She is a Clinical Research Associate at Axelys Santé.
